Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 301–400 of 1,014
Orlando, C., Ster, J., Gerber, U., Fawcett, J. W., & Raineteau, O. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2406-12.2012 · Cited by 153
“Several studies have demonstrated a role for ChABC treatment in promoting functional plasticity in models of CNS pathologies (Bradbury et al., 2002; Pizzorusso et al., 2002; Gogolla et al., 2009; Kwok et al., 2011).”
BackgroundSelf-citationDecellularization for the retention of tissue niches
Moffat, D., Ye, K., & Jin, S. (2022) · Journal of Tissue Engineering · doi:10.1177/20417314221101151 · Cited by 152
Wearable Triboelectric Nanogenerators for Therapeutics
Xiao, X., Chen, G., Libanori, A., & Chen, J. (2021) · Trends in Chemistry · doi:10.1016/j.trechm.2021.01.001 · Cited by 150
Raiker, S. J., Lee, H., Baldwin, K. T., Duan, Y., Shrager, P., & Giger, R. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0895-10.2010 · Cited by 145
“Injury-induced neuronal sprouting and structural plasticity is enhanced by antagonism of extracellular growth inhibitors (Bradbury et al., 2002; Cafferty et al., 2010; Hoeffer and Klann, 2010; J. K. Lee et al., 2010), elevated neurotrophins (Blesch and Tuszynski, 2009), activation of intrinsic growth programs (Romero…”
Background“Targeting astrocytes in CNS injury and disease: A translational research approach”
Filous, A. R., & Silver, J. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.03.009 · Cited by 160
Nagappan, P. G., Chen, H., & Wang, D. Y. (2020) · Military Medical Research · doi:10.1186/s40779-020-00259-3 · Cited by 185
Plasticity After Spinal Cord Injury: Relevance to Recovery and Approaches to Facilitate It
Onifer, S. M., Smith, G. M., & Fouad, K. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0034-4 · Cited by 171
Use of polysialic acid in repair of the central nervous system
El Maarouf, A., Petridis, A. K., & Rutishauser, U. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608036103 · Cited by 150
Matrix Metalloproteinase-9 Facilitates Glial Scar Formation in the Injured Spinal Cord
Hsu, J.-Y. C., Bourguignon, L. Y. W., Adams, C. M., Peyrollier, K., Zhang, H., Fandel, T., Cun, C. L., Werb, Z., & Noble-Haeusslein, L. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2287-08.2008 · Cited by 145
“Enzymatic treatment of the injured spinal cord with chondroitinase ABC significantly promotes axonal regeneration and recovery of motor function as a result of CSPG degradation (Bradbury et al., 2002; Chau et al., 2004; Massey et al., 2008; Tom and Houlé, 2008).”
BackgroundMyelin associated inhibitors: A link between injury-induced and experience-dependent plasticity
Akbik, F., Cafferty, W. B. J., & Strittmatter, S. M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.006 · Cited by 147
“While myelin is an important source of inhibition in the CNS, axon growth can also be modulated by a variety of other molecules including increased neurotrophic support[8] and digestion of extracellular matrix protein side-chains[9], both of which have been shown to support axon regeneration in vitro and in vivo.”
BackgroundKamei, N., Tanaka, N., Oishi, Y., Hamasaki, T., Nakanishi, K., Sakai, N., & Ochi, M. (2007) · Spine · doi:10.1097/brs.0b013e318059afab · Cited by 156
Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function
Sims, N. R., & Yew, W. P. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2016.12.016 · Cited by 159
“Axonal regeneration and improved function is promoted by treatment with the enzyme, chondroitinase ABC, to degrade the glycosaminoglycan chains (Bradbury et al., 2002; Moon et al., 2001; Rolls et al., 2009).”
Olfactory ensheathing cells (OECs) and the treatment of CNS injury: advantages and possible caveats
Barnett, S. C., & Riddell, J. S. (2004) · Journal of Anatomy · doi:10.1111/j.1469-7580.2004.00257.x · Cited by 147
“enzymatic treatments for chondroitin sulphate proteoglycans (Bradbury et al. 2002), antibodies to Nogo receptors (Brittis & Flanagan, 2001; Huber & Schwab, 2000; McKerracher & Winton, 2002), and lastly (4) providing a permissive growth environment by transplanting neural cells.”
Backgroundde Vivo, L., Landi, S., Panniello, M., Baroncelli, L., Chierzi, S., Mariotti, L., Spolidoro, M., Pizzorusso, T., Maffei, L., & Ratto, G. M. (2013) · Nature Communications · doi:10.1038/ncomms2491 · Cited by 148
Gao, M., Lu, P., Bednark, B., Lynam, D. A., Conner, J. M., Sakamoto, J. S., & Tuszynski, M. H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.070 · Cited by 158
Ahuja, C. S., Mothe, A. J., Khazaei, M., Badhiwala, J. H., Gilbert, E. A. B., van der Kooy, D., Morshead, C. M., Tator, C. H., & Fehlings, M. G. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0135 · Cited by 156
Chondroitin sulfates and their binding molecules in the central nervous system
Djerbal, L., Lortat-Jacob, H., & Kwok, J. (2017) · Glycoconjugate Journal · doi:10.1007/s10719-017-9761-z · Cited by 144
“Enzymatic removal of CSs using ChABC promotes functional recovery after spinal cord injury (SCI) in adult rats [73, 74].”
MethodNeuroactive Chondroitin Sulfate Glycomimetics
Rawat, M., Gama, C. I., Matson, J. B., & Hsieh-Wilson, L. C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja709993p · Cited by 142
Tom, V. J., Sandrow-Feinberg, H. R., Miller, K., Santi, L., Connors, T., Lemay, M. A., & Houlé, J. D. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3641-09.2009 · Cited by 141
“Digestion of CSPGs by the bacterial enzyme chondroitinase ABC (ChABC), which cleaves the inhibitory sugar moiety from the protein core of CSPG, results in improved regrowth of acutely injured axons in vivo and has been associated with some functional recovery (Bradbury et al., 2002; Caggiano et al., 2005; Houle et al.…”
BackgroundThe perineuronal net component of the extracellular matrix in plasticity and epilepsy
McRae, P. A., & Porter, B. E. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.007 · Cited by 143
“ChABC treatment has also been shown to enhance axonal regeneration along with locomotor and proprioceptive recovery following acute cervical dorsal column crush (Bradbury et al., 2002).”
BackgroundMethodChondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ
Pendleton, J. C., Shamblott, M. J., Gary, D. S., Belegu, V., Hurtado, A., Malone, M. L., & McDonald, J. W. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.04.003 · Cited by 153
Li, W., Chen, J., Zhao, S., Huang, T., Ying, H., Trujillo, C., Molinaro, G., Zhou, Z., Jiang, T., Liu, W., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28787-7 · Cited by 154
Fenrich, K. K., & Gordon, T. (2004) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100053798 · Cited by 169
Induction of corticospinal regeneration by lentiviral trkB-induced Erk activation
Hollis, E. R., Jamshidi, P., Löw, K., Blesch, A., & Tuszynski, M. H. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810624106 · Cited by 141
“Eventual functional bridging of axons beyond a lesion site will likely require additional interventions, including trophic factor gradients extending beyond the lesion site (46, 47), modification of the inhibitory environment (9, 10, 48), or both.”
BackgroundGlycosaminoglycans detection methods: Applications of mass spectrometry
Kubaski, F., Osago, H., Mason, R. W., Yamaguchi, S., Kobayashi, H., Tsuchiya, M., Orii, T., & Tomatsu, S. (2016) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2016.09.005 · Cited by 155
Pearse, D. D., Marcillo, A. E., Oudega, M., Lynch, M. P., Wood, P. M., & Bunge, M. B. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041953876 · Cited by 146
Struve, J., Maher, P. C., Li, Y., Kinney, S., Fehlings, M. G., Kuntz, C., & Sherman, L. S. (2005) · Glia · doi:10.1002/glia.20215 · Cited by 138
“…is that they can inhibit axonal regeneration by forming both chemical barriers, such as chondroitin sulfate proteoglycans and other substances, and mechanical barriers that inhibit axonal growth (Snow et al., 1990; McKeon et al., 1991; Davies et al., 1997; Bradbury et al., 2002; Yick et al., 2003).”
BackgroundNetrin-1 Is a Novel Myelin-Associated Inhibitor to Axon Growth
Löw, K., Culbertson, M., Bradke, F., Tessier-Lavigne, M., & Tuszynski, M. H. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4906-07.2008 · Cited by 137
“, 2005); this and several other chondroitin sulfate proteoglycan family members are enriched at nodes of Ranvier as well as in regions surrounding sites of spinal cord injury (Davies et al., 1997; Wang et al., 1997; Bradbury et al., 2002; Jones et al., 2002, 2003b; Properzi et al., 2005).”
BackgroundRho-ROCK Inhibition in the Treatment of Spinal Cord Injury
Forgione, N., & Fehlings, M. G. (2013) · World Neurosurgery · doi:10.1016/j.wneu.2013.01.009 · Cited by 140
Ylera, B., Ertürk, A., Hellal, F., Nadrigny, F., Hurtado, A., Tahirović, S., Oudega, M., Kirchhoff, F., & Bradke, F. (2009) · Current Biology · doi:10.1016/j.cub.2009.04.017 · Cited by 144
Setting the stage for functional repair of spinal cord injuries: a cast of thousands
Ramer, L. M., Ramer, M. S., & Steeves, J. D. (2005) · Spinal Cord · doi:10.1038/sj.sc.3101715 · Cited by 159
Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology
Yang, S., Cacquevel, M., Saksida, L. M., Bussey, T. J., Schneider, B. L., Aebischer, P., Melani, R., Pizzorusso, T., Fawcett, J. W., & Spillantini, M. G. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.11.013 · Cited by 138
“Previous work using ChABC to promote plasticity has shown recovery in function in focal lesions such as spinal cord injury and stroke (Bradbury et al., 2002; Soleman et al., 2012); the present work shows that functional restoration can also be achieved in the presence of the more distributed neuronal dysfunction and l…”
BackgroundSelf-citationCorvetti, L., & Rossi, F. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0683-05.2005 · Cited by 138
“, 2005), in which they contribute to hampering axon regeneration (Davies et al., 1997; Moon et al., 2001; Bradbury et al., 2002; Grimpe and Silver, 2002; Jones and Tuszynski, 2002) or compensatory sprouting (Tropea et al.”
BackgroundInfluentialHow does chondroitinase promote functional recovery in the damaged CNS?
Crespo, D., Asher, R. A., Lin, R., Rhodes, K. E., & Fawcett, J. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.05.001 · Cited by 157
Self-citationCan injured adult CNS axons regenerate by recapitulating development?
Hilton, B. J., & Bradke, F. (2017) · Development · doi:10.1242/dev.148312 · Cited by 132
“…treatment with chondroitinase-ABC reactivates this developmental plasticity (Pizzorusso et al., 2002), while chondroitinase-ABC treatment enhances axon growth in part by facilitating expression of the same regeneration-associated genes that mediate developmental outgrowth (Bradbury et al., 2002).”
BackgroundWang, J., Wang, H., He, T., He, B., Thakor, N. V., & Lee, C. (2019) · Advanced Science · doi:10.1002/advs.201900149 · Cited by 142
Single-cell and spatial atlases of spinal cord injury in the Tabulae Paralytica
Skinnider, M. A., Gautier, M., Teo, A. Y. Y., Kathe, C., Hutson, T. H., Laskaratos, A., de Coucy, A., Regazzi, N., Aureli, V., James, N. D., et al. (2024) · Nature · doi:10.1038/s41586-024-07504-y · Cited by 159
Mason, M. R. J., Lieberman, A. R., & Anderson, P. N. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02809.x · Cited by 137
Extracellular matrix protein expression is brain region dependent
Dauth, S., Grevesse, T., Pantazopoulos, H., Campbell, P. H., Maoz, B. M., Berretta, S., & Parker, K. K. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.23965 · Cited by 134
“As a first step in characterizing the wide range of ECM molecules in the rat brain, we quantitatively analyzed the distribution of Aggr, Brev, and TnR, due to their established roles in brain development, plasticity, and neurite outgrowth (Bradbury et al., 2002; Lau et al., 2013).”
BackgroundSelective Modulation of A1 Astrocytes by Drug-Loaded Nano-Structured Gel in Spinal Cord Injury
Vismara, I., Papa, S., Veneruso, V., Mauri, E., Mariani, A., De Paola, M., Affatato, R., Rossetti, A., Sponchioni, M., Moscatelli, D., et al. (2020) · ACS Nano · doi:10.1021/acsnano.9b05579 · Cited by 137
Reactive Astrogliosis: Implications in Spinal Cord Injury Progression and Therapy
Li, X., Li, M., Tian, L., Chen, J., Liu, R., & Ning, B. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9494352 · Cited by 133
“showed that injection of chondroitinase ABC, a CSPGdegrading enzyme, into the lesion could inactivate the CSPGs in the scar tissue, which can effectively induce an improvement of motor function [112].”
BackgroundTan, A. M., Colletti, M., Rorai, A. T., Skene, J. H. P., & Levine, J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3900-05.2006 · Cited by 133
“Two microliters of a 1.5% solution of cholera toxin B subunit (CTB) (List Biological Laboratories, Campbell, CA) were injected into the nerve using a handheld Hamilton syringe equipped with a 32 gauge needle (Bradbury et al., 2002).”
BackgroundMethodInfluentialTranscriptional regulation of scar gene expression in primary astrocytes
Gris, P., Tighe, A., Levin, D., Sharma, R., & Brown, A. (2007) · Glia · doi:10.1002/glia.20537 · Cited by 130
“After 12 h or 3, 7, 21, or 42 days, the rats were anesthetized with 1:2 ratio of ketamine: xylazine (0.13 mL/100 g) the injured segment of the spinal cord was removed, immediately homogenized in ice cold Trizol solution (Invitrogen) and the RNA extracted as described (Carmel et al., 2001).”
MethodInfluentialExtracellular matrix and traumatic brain injury
George, N., & Geller, H. M. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24151 · Cited by 142
“chABC has been shown to promote recovery of function from spinal cord injury (Bradbury et al., 2002), at least in part by increasing plasticity and sprouting (Barritt et al.”
BackgroundDzyubenko, E., Gottschling, C., & Faissner, A. (2016) · Neural Plasticity · doi:10.1155/2016/5214961 · Cited by 134
“This degradation results in enhanced neuronal plasticity, for example, a higher expression of synaptic proteins in rat hippocampal neurons [130], restoration of ocular dominance plasticity in the adult cat visual cortex [136, 152], and enhanced regeneration of sensory projections and corticospinal tract axons within t…”
BackgroundTransplanted Olfactory Ensheathing Cells Promote Regeneration of Cut Adult Rat Optic Nerve Axons
Li, Y., Sauvé, Y., Li, D., Lund, R. D., & Raisman, G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07783.2003 · Cited by 134
“On the other hand, the astrocytic meshwork of the distal optic nerve stump would be rich in inhibitory molecules such as chondroitin sulfate proteoglycans (Davies et al., 1997; Bradbury et al., 2002; Grimpe and Silver, 2002).”
Hill, C. E., Pröschel, C., Noble, M., Mayer-Pröschel, M., Gensel, J. C., Beattie, M. S., & Bresnahan, J. C. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.043 · Cited by 137
Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair
Rosenzweig, E. S., & McDonald, J. W. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00007 · Cited by 148
Filous, A. R., Tran, A., Howell, C. J., Busch, S. A., Evans, T. A., Stallcup, W. B., Kang, S. H., Bergles, D. E., Lee, S.-I., Levine, J. M., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1309-14.2014 · Cited by 129
“Ch’ase is an enzyme that cleaves the inhibitory GAG chains and has been reported to improve neurite outgrowth on CSPG-containing substrates (Snow et al., 1990; Bradbury et al., 2002; Shen et al., 2009).”
BackgroundGardiner, N. J. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20950 · Cited by 132
“Removal of CSPGs, by central delivery of chondroitinase ABC, promotes axon regeneration in the injured CNS (Bradbury et al., 2002).”
BackgroundChondroitinase improves anatomical and functional outcomes after primate spinal cord injury
Rosenzweig, E. S., Salegio, E. A., Liang, J. J., Weber, J. L., Weinholtz, C. A., Brock, J. H., Moseanko, R., Hawbecker, S., Pender, R., Cruzen, C. L., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0424-1 · Cited by 130
Self-citationNandini, C., & Sugahara, K. (2006) · Advances in pharmacology · doi:10.1016/s1054-3589(05)53012-6 · Cited by 133
Restoring walking after spinal cord injury
Fouad, K., & Pearson, K. G. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.04.003 · Cited by 174
“…has frequently been used in combination with other approaches such as bridges of Schwann (Bamber et al., 2001) or fetal cells (Coumans et al., 2001), and in conjunction with the IN-1 antibody to neutralize the myelin associated inhibitor for neurite growth Nogo-A (von Meyenburg et al., 1998).”
BackgroundInfluentialSemaphorins in axon regeneration: developmental guidance molecules gone wrong?
Pasterkamp, R. J., & Verhaagen, J. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1892 · Cited by 128
“In light of these observations it is interesting that chABC treatment promotes regeneration of spinal axons (Bradbury et al. 2002) and reinstates synaptic plasticity in the visual cortex after the critical period (Pizzorusso et al.”
BackgroundInfluentialPyka, M., Wetzel, C., Aguado, A., Geissler, M., Hatt, H., & Faissner, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07690.x · Cited by 131
“have been extensively investigated in the context of regeneration (Fidler et al., 1999; Bradbury et al., 2002; Carulli et al., 2005).”
BackgroundVersican and the regulation of cell phenotype in disease
Wight, T. N., Kinsella, M. G., Evanko, S. P., Potter-Perigo, S., & Merrilees, M. J. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.028 · Cited by 128
“The importance of the hyalectins in preventing nerve regeneration is further highlighted by studies that show that degradation of CS chains by chondroitinase ABC lyase treatment following spinal cord injury in experimental animals promotes regeneration of both ascending and descending corticospinal-tract axons [126].”
Brambilla, R., Hurtado, A., Persaud, T., Esham, K., Pearse, D. D., Oudega, M., & Bethea, J. R. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06190.x · Cited by 129
NG2: a component of the glial scar that inhibits axon growth
Tan, A. M., Zhang, W., & Levine, J. M. (2005) · Journal of Anatomy · doi:10.1111/j.1469-7580.2005.00452.x · Cited by 130
“Third, treatment of damaged CNS tissue with chondroitinase ABC, a bacterial enzyme that removes the chondroitin sulphate GAG chains from proteoglycan core proteins and promotes axon regrowth and functional recovery (Moon et al. 2001; Bradbury et al. 2002).”
BackgroundKarimi‐Abdolrezaee, S., Schut, D., Wang, J., & Fehlings, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037589 · Cited by 145
“For example, the inhibitory influence of astrogliosis on limiting axonal regeneration and plasticity after SCI is very well established [3,16,17,36,37,38,39,40].”
BackgroundDefeating inhibition of regeneration by scar and myelin components
Fawcett, J. W., Schwab, M. E., Montani, L., Brazda, N., & Müller, H. W. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52137-8.00031-0 · Cited by 135
Self-citationGliem, M., Krammes, K., Liaw, L., van Rooijen, N., Hartung, H.-P., & Jander, S. (2015) · Glia · doi:10.1002/glia.22885 · Cited by 127
“Both astroglial (Bradbury et al., 2002; Faulkner, 2004; Okada et al., 2006; Wanner et al., 2013) and fibrous constituents (Gliem et al.”
BackgroundInfluentialTsuji, O., Sugai, K., Yamaguchi, R., Tashiro, S., Nagoshi, N., Kohyama, J., Iida, T., Ohkubo, T., Itakura, G., Isoda, M., et al. (2019) · Stem Cells · doi:10.1002/stem.2926 · Cited by 128
Johnson, P. J., Parker, S. R., & Sakiyama‐Elbert, S. E. (2010) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32343 · Cited by 128
“Previously, it has been found, that reducing or removing inhibitory components within the glial scar following SCI increased axonal regeneration.(50,51) Likewise, the decrease in astrocyte density in our study could have increased the ability of axons to extend into the lesion site by reducing the strength of the inhi…”
BackgroundJames, N. D., Bartus, K., Grist, J., Bennett, D. L. H., McMahon, S. B., & Bradbury, E. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4306-11.2011 · Cited by 126
“, 2010; Zorner and Schwab, 2010) and chondroitin sulfate proteoglycans (CSPGs) (Bradbury et al., 2002; Alilain et al., 2011; Bradbury and Carter, 2011) or by growth-promoting strategies (Alto et al.”
BackgroundSelf-citationLi, G., Che, M., Zhang, K., Qin, L.-N., Zhang, Y., Chen, R., Rong, L., Liu, S., Ding, Y., Shen, H., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.059 · Cited by 127
Morita, T., Sasaki, M., Kataoka-Sasaki, Y., Nakazaki, M., Nagahama, H., Oka, S., Oshigiri, T., Takebayashi, T., Yamashita, T., Kocsis, J. D., et al. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.037 · Cited by 139
A synthetic synaptic organizer protein restores glutamatergic neuronal circuits
Suzuki, K., Elegheert, J., Song, I., Sasakura, H., Senkov, O., Matsuda, K., Kakegawa, W., Clayton, A. J., Chang, V. T., Ferrer-Ferrer, M., et al. (2020) · Science · doi:10.1126/science.abb4853 · Cited by 123
“For comparison, we separately injected chondroitinase ABC (ChABC), an enzyme that promotes robust nerve regeneration (52), as well as Cbln1 to the lesioned spinal cord.”
MethodTobias, C. A., Han, S. S. W., Shumsky, J. S., Kim, D., Tumolo, M., Dhoot, N. O., Wheatley, M. A., Fischer, I., Tessler, A. R., & Murray, M. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.138 · Cited by 127
“Slides containing spinal cord tissue were rinsed three times for 30 min each with TBST (50 mM Tris buffered saline containing 0.5% Triton X-100, pH 10.0), then incubated with the avidin-biotinylated-complex (ABC kit) at room temperature for two hours.”
BackgroundInfluentialRegeneration of the adult central nervous system
Case, L. C., & Tessier‐Lavigne, M. (2005) · Current Biology · doi:10.1016/j.cub.2005.09.008 · Cited by 135
Hikino, M., Mikami, T., Faissner, A., Vilela-Silva, A.-C. E. S., Pavão, M. S. G., & Sugahara, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308169200 · Cited by 124
Basic Advances and New Avenues in Therapy of Spinal Cord Injury
Dobkin, B. H., & Havton, L. A. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104338 · Cited by 139
An ice‐templated, linearly aligned chitosan‐alginate scaffold for neural tissue engineering
Francis, N. L., Hunger, P. M., Donius, A. E., Riblett, B. W., Zavaliangos, A., Wegst, U. G. K., & Wheatley, M. A. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34668 · Cited by 125
NG2 Glial Cells Provide a Favorable Substrate for Growing Axons
Yang, Z., Suzuki, R., Daniels, S. B., Brunquell, C. B., Sala, C. J., & Nishiyama, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4247-05.2006 · Cited by 123
“, 2002b), a characteristic shared by many chondroitin sulfate proteoglycans (Smith et al., 1986, 1990; Hoke and Silver, 1996; Moon et al., 2001; Bradbury et al., 2002; Silver and Miller, 2004).”
BackgroundTester, N. J., Plaas, A., & Howland, D. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21199 · Cited by 125
“After central nervous system (CNS) and peripheral nervous system (PNS) injuries, CSPGs are up-regulated and thought to inhibit axonal regrowth (Pindzola et al., 1993; Zuo et al., 1998a; Lemons et al., 1999).”
BackgroundMethodInfluentialErschbamer, M., Pernold, K., & Olson, L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.1037-07.2007 · Cited by 123
“Rapid improvements in the first 3 weeks after experimental incomplete spinal cord injury have been observed in response to other treatments of experimental SCI, such as NgR antibodies, C3, or chondroitinase (Bradbury et al., 2002; Dergham et al., 2002; GrandPre et al., 2002; Filbin, 2003).”
BackgroundSlit and glypican‐1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain
Hagino, S., Iseki, K., Mori, T., Zhang, Y., Hikake, T., Yokoya, S., Takeuchi, M., Hasimoto, H., Kikuchi, S., & Wanaka, A. (2003) · Glia · doi:10.1002/glia.10207 · Cited by 120
“, 2001) and chondroitinase ABC treatment (Bradbury et al., 2002) enhance axonal regeneration and recovery of CNS functions.”
Backgroundvan den Oever, M. C., Lubbers, B. R., Goriounova, N. A., Li, K. W., van der Schors, R. C., Loos, M., Riga, D., Wiskerke, J., Binnekade, R., Stegeman, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.90 · Cited by 130
“In addition to structural changes, opiate exposure also results in a change in synapse physiology of neurons in the ventral-tegmental area (”
BackgroundContactin-1 is a functional receptor for neuroregulatory chondroitin sulfate-E
Mikami, T., Yasunaga, D., & Kitagawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809227200 · Cited by 124
Disinhibition of neurite growth to repair the injured adult CNS: Focusing on Nogo
Gonzenbach, R. R., & Schwab, M. E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7170-3 · Cited by 136
Recent advances in nanotherapeutic strategies for spinal cord injury repair
Song, Y. H., Agrawal, N. K., Griffin, J. M., & Schmidt, C. E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.011 · Cited by 130
von Holst, A., Sirko, S., & Faissner, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0422-06.2006 · Cited by 124
“The bacterial enzyme ChABC specifically degrades CS-GAGs but does not directly affect the core proteins of chondroitin sulfate proteoglycans (Bradbury et al., 2002).”
BackgroundSoleman, S., Yip, P. K., Duricki, D. A., & Moon, L. D. F. (2012) · Brain · doi:10.1093/brain/aws027 · Cited by 123
“Our results extend previous work showing chondroitinase ABC promotes behavioural recovery after different neurological injuries (Bradbury et al., 2002; Pizzorusso et al., 2006; Galtrey et al., 2007; Cafferty et al., 2008; Garcia-Alias et al., 2009; Alilain et al., 2011).”
BackgroundResultSelf-citationTropea, D., Caleo, M., & Maffei, L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07034.2003 · Cited by 123
“Our data are also consistent with previous electrophysiological data showing that C-ABC treatment promotes formation of functional connections by regenerated axons (Bradbury et al., 2002).”
InfluentialNandini, C. D., Mikami, T., Ohta, M., Itoh, N., Akiyama-Nambu, F., & Sugahara, K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404746200 · Cited by 122
Wahl, A.-S., & Schwab, M. E. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00381 · Cited by 135
“Chondroitinase ABC treatment reduces scar formation and enhances axonal regeneration and sprouting as first shown in several studies after experimental spinal cord injury (Moon et al., 2001; Bradbury et al., 2002; Huang et al., 2006).”
Advancing models of neural development with biomaterials
Roth, J. G., Huang, M. S., Li, T. L., Feig, V. R., Jiang, Y., Cui, B., Greely, H. T., Bao, Z., Pașca, S. P., & Heilshorn, S. C. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00496-y · Cited by 127
Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
Lima, R., Monteiro, A., Salgado, A. J., Monteiro, S., & Silva, N. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213833 · Cited by 142
“Through the breakdown of CPSGs chains [232], ChABC was able to promote functional recovery of SCI rats [232].”
BackgroundRegeneration of descending axon tracts after spinal cord injury
Deumens, R., Koopmans, G. C., & Joosten, E. A. J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.10.004 · Cited by 131
Chondroitin sulphate proteoglycans: Key modulators of spinal cord and brain plasticity
Bartus, K., James, N. D., Bosch, K. D., & Bradbury, E. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.008 · Cited by 136
Self-citationCritical Care and Perioperative Management in Traumatic Spinal Cord Injury
Stevens, R. D., Bhardwaj, A., Kirsch, J. R., & Mirski, M. A. (2003) · Journal of Neurosurgical Anesthesiology · doi:10.1097/00008506-200307000-00009 · Cited by 121
Li, C., Jiao, G., Wu, W., Wang, H., Ren, S., Zhang, L., Zhou, H., Liu, H., & Chen, Y. (2019) · Cell Transplantation · doi:10.1177/0963689719870999 · Cited by 120
Tashiro, S., Nishimura, S., Iwai, H., Sugai, K., Zhang, L., Shinozaki, M., Iwanami, A., Toyama, Y., Liu, M., Okano, H., et al. (2016) · Scientific Reports · doi:10.1038/srep30898 · Cited by 120
Advances in Biomaterial‐Based Spinal Cord Injury Repair
Shen, H., Fan, C., You, Z., Xiao, Z., Zhao, Y., & Dai, J. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202110628 · Cited by 129
Singhal, S., Lawrence, J. M., Bhatia, B., Ellis, J. S., Kwan, A., MacNeil, A., Luthert, P. J., Fawcett, J. W., Perez, M.-T., Khaw, P. T., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0898 · Cited by 127
Self-citationTransplantation strategies to promote repair of the injured spinal cord
Bunge, M. B., & Pearse, D. D. (2003) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2003.08.0055 · Cited by 119
“Another pursuit to overcome inhibitory factors is to deliver enzymes that prevent the formulation of or degrade chondroitin sulfate proteoglycans as they accumulate near the site of injury [7,8].”
BackgroundLi, X., Liu, D., Xiao, Z., Zhao, Y., Han, S., Chen, B., & Dai, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.012 · Cited by 119
Lin, R., Kwok, J. C. F., Crespo, D., & Fawcett, J. W. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05066.x · Cited by 115
Self-citationThe Glial Scar-Monocyte Interplay: A Pivotal Resolution Phase in Spinal Cord Repair
Shechter, R., Raposo, C., London, A., Sagi, I., & Schwartz, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027969 · Cited by 110
“Scar deposition is an essential response to the trauma, that should be tightly controlled [9]; although it is essential for the repair at the acute phase [9], the scar becomes an obstacle in the subsequent steps [3,5,9].”
BackgroundInfluentialNatale, J. E., Ahmed, F., Cernak, I., Stoica, B., & Faden, A. I. (2003) · Journal of Neurotrauma · doi:10.1089/089771503770195777 · Cited by 115
“In spinal cord injury, modulating the ECM may enhance axonal growth and regeneration (Bradbury et al., 2002), but the ECM has received less attention in TBI.”
Laabs, T. L., Wang, H., Katagiri, Y., McCann, T., Fawcett, J. W., & Geller, H. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2807-07.2007 · Cited by 117
“…of axon regeneration (Silver and Miller, 2004). cABC is effective at removal of GAG chains at the lesion site in vivo (McKeon et al., 1995; Moon et al., 2001; Bradbury et al., 2002), distal to the lesion site, when combined with a peripheral nerve graft (Houle et al., 2006), as well as in vitro.”
BackgroundSelf-citation
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.